| Myasthenia gravis in the elderly. | |
| | |
MedLine Citation:
|
PMID: 1262678 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
During a 15-year period in Jerusalem, myasthenia gravis was diagnosed in 15 patients aged 60 or older. At this age, diagnosis is difficult because of such possible associated conditions as cerebrovascular and cardiovascular arteriosclerotic diseases or bronchopulmonary disorders. The clinical course often is complicated by these associated conditions, and also by their treatment. Seven of the patients died within 4 years of the onset of their illness, but only 5 because of myasthenia gravis. This disease represents an important diagnostic and therapeutic problem in elderly patients. |
| | |
Authors:
|
Y Herishanu; O Abramsky; S Feldman |
Related Documents
:
|
16352338 - Haematological malignancies--a predictor of a poor outcome in patients with bacteraemia. 7864298 - Nuclear morphometry in xeroderma pigmentosum-associated malignant melanomas. 84468 - Porphyria cutanea tarda associated with lymphoma. 19278738 - Association of hla-a in autoimmune myasthenia gravis with thymoma. 1898838 - Lupus anticoagulant inhibition of in vitro prostacyclin release is associated with a th... 21619388 - Efficacy of intravenous iron in treating iron deficiency anaemia in patients with infla... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Journal of the American Geriatrics Society Volume: 24 ISSN: 0002-8614 ISO Abbreviation: J Am Geriatr Soc Publication Date: 1976 May |
Date Detail:
|
Created Date: 1976-07-06 Completed Date: 1976-07-06 Revised Date: 2008-03-10 |
Medline Journal Info:
|
Nlm Unique ID: 7503062 Medline TA: J Am Geriatr Soc Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 228-31 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Aged Anti-Bacterial Agents / adverse effects, therapeutic use Child Child, Preschool Female Humans Infant Male Middle Aged Myasthenia Gravis / complications, diagnosis*, drug therapy Neostigmine / therapeutic use Prednisone / therapeutic use Pyridostigmine Bromide / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Bacterial Agents; 101-26-8/Pyridostigmine Bromide; 53-03-2/Prednisone; 59-99-4/Neostigmine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The care of decubitus ulcers pressure sores.
Next Document: Immunisation of sheep against Schistosoma mattheei using either irradiated cercariae or irradiated s...